Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for Non-arteritic Anterior Ischemic Optic Neuropathy
IRCT201102275914N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of erythropoietin in non-arteritic anterior ischemic optic neuropathy (NAION), sponsored by Tehran University of Medical Sciences. Started Mar 2011; status: completed.
02
Drugs
erythropoietin
03
Conditions
non-arteritic anterior ischemic optic neuropathy (NAION)
Beyond the preview
Go deeper on IRCT201102275914N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201102275914N2.